Related references
Note: Only part of the references are listed.Drug-Gene Modeling in Pediatric T-Cell Acute Lymphoblastic Leukemia Highlights Importance of 6-Mercaptopurine for Outcome
Alex H. Beesley et al.
CANCER RESEARCH (2013)
Biology of Childhood Acute Lymphoblastic Leukemia
Luca Lo Nigro
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation
G. M. Marshall et al.
LEUKEMIA (2013)
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells
Kimberly A. Hartwell et al.
NATURE CHEMICAL BIOLOGY (2013)
Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials
E. van de Steeg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
How I treat relapsed childhood acute lymphoblastic leukemia
Franco Locatelli et al.
BLOOD (2012)
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Ching-Hon Pui et al.
BLOOD (2012)
Applications of Connectivity Map in drug discovery and development
Xiaoyan A. Qu et al.
DRUG DISCOVERY TODAY (2012)
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia
Vivek A. Bhadri et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2012)
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E. Winter et al.
NATURE CHEMICAL BIOLOGY (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts
Barbara Szymanska et al.
PLOS ONE (2012)
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia
Jitesh D. Kawedia et al.
BLOOD (2011)
Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
Vivek A. Bhadri et al.
BMC GENOMICS (2011)
Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
Emmanuelle Clappier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Statins inhibit T-acute lymphoblastic leukemia cell adhesion and migration through Rap1b
Elvira Infante et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia
Takaomi Sanda et al.
BLOOD (2010)
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
Petra S. Bachmann et al.
BLOOD (2010)
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
Ismael Samudio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
Alex H. Beesley et al.
MOLECULAR CANCER (2010)
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
A. H. Beesley et al.
BRITISH JOURNAL OF CANCER (2009)
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia
Anthony Calabro et al.
ANTI-CANCER DRUGS (2008)
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies
Paolo Macor et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia
L. Charles Bailey et al.
LANCET ONCOLOGY (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi et al.
BLOOD (2007)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia
GJL Kaspers et al.
EUROPEAN JOURNAL OF CANCER (2005)
Inhibition of β-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARγ agonists
VB Andela et al.
FEBS LETTERS (2005)
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem et al.
BLOOD (2004)
The mevalonate synthesis pathway as a therapeutic target in cancer
VB Andela et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia
ML Den Boer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Systematic discovery of multicomponent therapeutics
AA Borisy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses
HY Li et al.
BLOOD (2003)
Role of peroxisome proliferator-activated receptor-γ in hematologic malignancies
M Konopleva et al.
CURRENT OPINION IN HEMATOLOGY (2002)
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse
RB Lock et al.
BLOOD (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Share Paper
